In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
December 11th, 2008 | 24 | No |
Popular Name: trilostane trilostane
Find On: PubMed — Wikipedia — Google
CAS Numbers: 13647-35-3 , 34140-59-5 , [34140-59-5]
(4alpha,5alpha,17beta)-3,17-dihydroxy-4,5-epoxyandrost-2-ene-2-carbonitrile
13647-35-3; D01180; Desopan (TN); Modrenal (TN); Trilostane (JAN/USAN)
3,17beta-dihydroxy-4alpha,5-epoxy-5alpha-androst-2-ene-2-carbonitrile
3,4,5-Trimethoxybenzoic acid 2-(dimethylamino)-2-phenylbutyl ester
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.56 | 4.2 | -11.31 | 1 | 4 | 0 | 74 | 329.44 | 0 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
UniProt Database Links | 3BHS_MYCTU | ChEBI |
ALOGPS_SOLUBILITY | 5.93e-02 g/l | DrugBank-withdrawn |
purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
Purity | 99.0% (HPLC) | APIChem |
Therapy | adrenocortical suppressant, antineoplastic, steroid biosynthesis inhibitor | SMDC Pharmakon |
Indications | Cushing’s syndrome | KeyOrganics Bioactives |
Target | Dehydrogenase | Selleck Chemicals |
Patent Database Links | EP1862182; EP1873258; EP1886695; GB2321455; US2001006962; US2003153544; US2004063677; US2007184076; US2007248537 | ChEBI |
No pre-computed analogs available. Try a structural similarity search.